3

OWNERSHIP DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: June 11, 2019
Period of Report: June 10, 2019
Accession Number: 0001144204-19-030591

View Document ↗ View on SEC.gov ↗